Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by schemehatcheron Dec 04, 2013 9:36pm
313 Views
Post# 21972616

Holy cow $5 -> $10 ->$22

Holy cow $5 -> $10 ->$22
I had a peak at the analyzer report today. It has a target of $5 US ( $5.35 CDN ). The report also shows a upside chance for $10 and even $22 if fully executed as planned. I am not that savvy, but can not understand why they would need to do a reverse split. I think this discussion is intentionally designed to keep potential buyers away.

Can anyone give a logical explanation as to why the report has not been placed directly beside the analysts name as it sits on the company website ?

A suggestion of common sence would say that if the warrants had no value, they would have been listed on the stock exchange many months ago so that they didn't simply become wallpaper, thanks to my friend for explaining that peace of logic.

schemehatcher
Bullboard Posts